Search
Icecure Medical Ltd
ICCMAdd to Watchlist
5.280USD
+0.420+8.64%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
14.82MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+8.64%
5 Days
-43.23%
1 Month
+2525.56%
6 Months
+765.43%
Year to Date
+765.43%
1 Year
+417.65%
Key Figures
4.980Open
5.563High
351.96KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.43%Turnover Ratio
4.860Prev. Close
4.980Low
1.06MTurnover
LossP/E Static
50.46P/B
0.00%Div Yield TTM
-129.00%ROA
1.40052wk High
0.10Volume Ratio
-15.32MNet Profit
81.18MShares
-0.2327EPS TTM
1.53Beta
-217.23%ROE
0.21552wk Low
12.00%Amplitude
32.38%Gross Margin
14.82MMarket Cap
483.83Reward/Risk
7.02%Risk Rate
TradingKey Stock Score of Icecure Medical Ltd
Currency: USD Updated: 2026-07-01Key Insights
Icecure Medical Ltd's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 102 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 44.50.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Icecure Medical Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive+
Icecure Medical Ltd Highlights
StrengthsRisks
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.38M.
Undervalued
The company’s latest PE is -22.69, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 628.53K shares, increasing 14.54% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 8.43.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
44.500
Target Price
+815.64%
Upside Space
Icecure Medical Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Icecure Medical Ltd Info
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
Ticker SymbolICCM
CompanyIcecure Medical Ltd
CEOShamir (Eyal)
Websitehttps://icecure-medical.com/
Related Instruments
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+5.81%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%Popular Instruments
52419.200
+164.900 (+0.32%)
29797.100
-2.200 (-0.01%)
7490.600
+15.100 (+0.20%)
14804.000
-551.000 (-3.59%)
68999.000
-486.000 (-0.70%)
6324.000
+48.600 (+0.77%)
67.194
-0.774 (-1.14%)
294.380
+5.020 (+1.73%)
197.580
-2.510 (-1.25%)
4068.460
+37.690 (+0.94%)
FAQs
What is the current price of Icecure Medical Ltd (ICCM)?
The current price of Icecure Medical Ltd (ICCM) is 5.28.
What is the symbol of Icecure Medical Ltd?
The ticker symbol of Icecure Medical Ltd is ICCM.
What is the 52-week high of Icecure Medical Ltd?
The 52-week high of Icecure Medical Ltd is 1.40.
What is the 52-week low of Icecure Medical Ltd?
The 52-week low of Icecure Medical Ltd is 0.21.
What is the market capitalization of Icecure Medical Ltd?
The market capitalization of Icecure Medical Ltd is 428.63M.
Is Icecure Medical Ltd (ICCM) currently rated as Buy, Hold, or Sell?
According to analysts, Icecure Medical Ltd (ICCM) has an overall rating of Buy, with a price target of 44.50.
What is the Earnings Per Share (EPS TTM) of Icecure Medical Ltd (ICCM)?
The Earnings Per Share (EPS TTM) of Icecure Medical Ltd (ICCM) is -0.24.